Please login to the form below

lenalidomide

This page shows the latest lenalidomide news and features for those working in and with pharma, biotech and healthcare.

behind Celgene’s cancer immunomodulator Revlimid (lenalidomide).

Safety scuppers combo trials with J&J/Genmab’s Darzalex

Additional studies of Darzalex as an add-on to regimens based on Celgene’s Revlimid (lenalidomide) and in ASCT-eligible patients could further expand the opportunity in previously-untreated patients, says
FDA clears first-line use for J&J

Later on, additional studies of Darzalex as an add-on to regimens based on Celgene’s Revlimid (lenalidomide) and in ASCT-eligible patients could further expand the opportunity in previously-untreated
FDA clears first-line use for J&J’s myeloma drug Darzalex

Later on, additional studies of Darzalex as an add-on to regimens based on Celgene’s Revlimid (lenalidomide) and in ASCT-eligible patients could further expand the opportunity in previously-untreated
FDA turns down Celgene’s filing for multiple sclerosis drug

Celgene has had a difficult few months, with the latest knock coming after its blood cancer blockbuster Revlimid (lenalidomide) failed to hit the mark in non-Hodgkin’s lymphoma, the failure
Amgen set for Kyprolis label boost after CHMP backing

Currently, Kyprolis is approved in the EU for us in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have

More from news
Approximately 14 fully matching, plus 77 partially matching documents found.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Multi-Channel Account Managers - Road / Homebased – Full or Part...: Competitive salary

Home based, Principal Medical Writer, Medical Communications: Excellent package

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Home based, Senior Medical Writer, Medical Communications: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Add my company

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape: Is it a solution to addressing the challenges of the value-based marketplace?...
Creativity has lost its worth: Creativity has lost its worth, and sadly it is undermining effectiveness...